Industry leaders outline priorities for healthcare, including AI integration, infrastructure expansion, and policy reforms ...
SunAct Cancer Institute has announced the commencement of Phase 2 clinical trials for Gamma Delta (gd) T-cell therapy, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback